IN2014DN08610A - - Google Patents

Info

Publication number
IN2014DN08610A
IN2014DN08610A IN8610DEN2014A IN2014DN08610A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A IN 8610DEN2014 A IN8610DEN2014 A IN 8610DEN2014A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A
Authority
IN
India
Prior art keywords
mammary gland
gland
peptides
cessation
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Jose Mario Iscovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of IN2014DN08610A publication Critical patent/IN2014DN08610A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN8610DEN2014 2012-03-19 2013-03-08 IN2014DN08610A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261612410P 2012-03-19 2012-03-19
PCT/IL2013/050214 WO2013140388A1 (en) 2012-03-19 2013-03-08 Peptides for management of lactation

Publications (1)

Publication Number Publication Date
IN2014DN08610A true IN2014DN08610A (enExample) 2015-05-22

Family

ID=49221927

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8610DEN2014 IN2014DN08610A (enExample) 2012-03-19 2013-03-08

Country Status (11)

Country Link
US (1) US9487557B2 (enExample)
EP (1) EP2828281B1 (enExample)
JP (1) JP6426599B2 (enExample)
CN (1) CN104321336B (enExample)
AU (1) AU2013236975B2 (enExample)
BR (1) BR112014023087A8 (enExample)
CA (1) CA2867557C (enExample)
ES (1) ES2759980T3 (enExample)
IL (1) IL234574B (enExample)
IN (1) IN2014DN08610A (enExample)
WO (1) WO2013140388A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
JP7441946B2 (ja) 2019-11-28 2024-03-01 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 非ヒト動物の乾乳におけるsglt-2阻害剤の使用
WO2022229965A1 (en) * 2021-04-28 2022-11-03 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391849B1 (en) 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
EP1375513A4 (en) * 2001-03-09 2006-04-12 Meiji Seika Kaisha IMMUNOSTIMULANTS
CN101247721B (zh) * 2005-05-02 2016-08-03 米勒尤迪斯公司 包括酪蛋白衍生肽的药物组合物及其使用方法
EA016039B1 (ru) * 2005-05-02 2012-01-30 Милеутис Лтд. Способы ухода за лактирующими животными и фармацевтические композиции, используемые для их осуществления
BRPI0815416A2 (pt) * 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos

Also Published As

Publication number Publication date
EP2828281A4 (en) 2015-11-11
WO2013140388A1 (en) 2013-09-26
CA2867557A1 (en) 2013-09-26
CN104321336A (zh) 2015-01-28
CN104321336B (zh) 2021-08-06
EP2828281B1 (en) 2019-09-18
BR112014023087A2 (pt) 2017-06-20
AU2013236975B2 (en) 2017-10-19
US20150093400A1 (en) 2015-04-02
BR112014023087A8 (pt) 2018-01-16
ES2759980T3 (es) 2020-05-12
JP6426599B2 (ja) 2018-11-21
AU2013236975A1 (en) 2014-10-23
IL234574B (en) 2020-09-30
EP2828281A1 (en) 2015-01-28
JP2015516377A (ja) 2015-06-11
US9487557B2 (en) 2016-11-08
CA2867557C (en) 2020-03-10

Similar Documents

Publication Publication Date Title
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
PH12016501512A1 (en) Treatment for resistant acne
NI201500024A (es) Anticuerpos y vacunas para utilizarse en el tratamiento de cánceres por ror1 y para inhibir la metástasis.
GB2541571A (en) Pharmaceutical compositions
SG10201903119QA (en) Polypeptide vaccine
IN2014DN10670A (enExample)
NZ730763A (en) Methods of treating a tauopathy
MX2015006681A (es) Formulaciones de vancomicina estabilizadas.
MX377729B (es) Métodos para tratamiento del melanoma.
MY168032A (en) Warm-Cool Beauty Treatment Device
PH12015501983A1 (en) Peptides and compositions for treatment of joint damage
MX2018007304A (es) Composiciones de interleucina-15 y sus usos.
MX357938B (es) Metodos para tratar y prevenir infecciones por staphylococcus aureus y afecciones asociadas.
EP4414376A3 (en) Novel depsipeptide and uses thereof
MX2015015506A (es) Peptidos antimicrobianos.
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
EA201692554A1 (ru) Менингококковые вакцины
MY191539A (en) Streptococcal vaccine
GB201118201D0 (en) Novel peptides
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
TN2014000518A1 (en) Reassortant btv and ahsv vaccines
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
IN2014DN08610A (enExample)
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.